In the tumor, IL-33 distribution is heterogeneous among patients, observing both nuclear and cytoplasmic staining in tumor epithelial cells, with stromal staining in fibroblast-like cells, mononuclear cells and endothelium (Figure 2A). The gene discussed is IL33; the disease is neoplasm.